R. Shull

发表

Genetically corrected autologous stem cells engraft, but host immune responses limit their utility in canine alpha-L-iduronidase deficiency.

C. Lutzko, D. Kohn, I. Dubé, 1999, Blood.

Noncirrhotic portal hypertension and nodular regenerative hyperplasia of the liver in dogs with mucopolysaccharidosis type I

J. Schneider, R. Denovo, M. Mcentee, 1998, Hepatology.

Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I.

A. Schmidtchen, M. Mcentee, D. Ward, 1996, Biochemical and molecular medicine.

Canine stem cell factor (c-kit ligand) supports the survival of hematopoietic progenitors in long-term canine marrow culture.

S. Suggs, F. Jacobsen, K. Langley, 1992, Experimental hematology.

Long-Term Neurological Effects of Bone Marrow Transplantation in a Canine Lysosomal Storage Disease

G. Constantopoulos, M. Breider, R. Shull, 1988, Pediatric Research.

Gene therapy for canine alpha-L-iduronidase deficiency: in utero adoptive transfer of genetically corrected hematopoietic progenitors results in engraftment but not amelioration of disease.

C. Lutzko, I. Dubé, A. Abrams-Ogg, 1999, Human gene therapy.

Ehrlichia canis-related polyarthritis in a dog.

R. Shull, J. Bellah, E. V. Selcer, 1986, Journal of the American Veterinary Medical Association.

Canine alpha-L-iduronidase deficiency. A model of mucopolysaccharidosis I.

C. W. Hall, G. Constantopoulos, E. Neufeld, 1982, The American journal of pathology.

Serum hyperviscosity syndrome associated with IgA multiple myeloma in two dogs

R. E. Barrett, R. Barrett, C. Osborne, 1978 .

Morphologic and biochemical studies of canine mucopolysaccharidosis I.

G. Constantopoulos, R. Helman, E. Neufeld, 1984, The American journal of pathology.

Enzyme replacement in a canine model of Hurler syndrome.

M. Mcentee, A. Jonas, E. Neufeld, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Cloning and characterization of cDNA encoding canine alpha-L-iduronidase. mRNA deficiency in mucopolysaccharidosis I dog.

D. Teplow, B. Sosa-Pineda, K. Menon, 1992, The Journal of biological chemistry.

Corneal opacity in canine MPS I. Changes after bone marrow transplantation.

G. Constantopoulos, J. Scott, R. Shull, 1989, Investigative ophthalmology & visual science.

Long-term effects of bone marrow transplantation in dogs with mucopolysaccharidosis I.

G. Constantopoulos, M. Breider, R. Shull, 1989, The American journal of pathology.

A canine model of human alpha-L-iduronidase deficiency.

G. Constantopoulos, E. Neufeld, E. Spellacy, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Alterations in neuron morphology in mucopolysaccharidosis type I

S. Walkley, M. Haskins, R. Shull, 2004, Acta Neuropathologica.

Lectin Histochemical Evalution of Neuronal Glycosaminoglycan Content Following Bone Marrow Transplantation in Dogs with MPS I

R. Shull, 1991 .

Impaired urea clearance in canine mucopolysaccharidosis I.

R. Shull, 1987, Veterinary clinical pathology.

Neurochemical Characterization of Canine α‐L‐Iduronidase Deficiency Disease (Model of Human Mucopolysaccharidosis I)

G. Constantopoulos, E. Neufeld, R. Shull, 1985, Journal of neurochemistry.

Fluorometric assay of alpha-L-iduronidase in serum for detection of affected and carrier animals in a canine model of mucopolysaccharidosis I.

N. Hastings, R. Shull, 1985, Clinical chemistry.

Bone marrow transplantation in canine mucopolysaccharidosis I. Effects within the central nervous system.

J. R. Smith, G. Constantopoulos, N. Hastings, 1987, The Journal of clinical investigation.

Myoblast gene therapy in canine mucopolysaccharidosis. I: Abrogation by an immune response to alpha-L-iduronidase.

M. Mcentee, D. Kohn, K. Pepper, 1996, Human gene therapy.

Humoral immune response limits gene therapy in canine MPS I [letter]

C. Lutzko, H. Kiem, I. Dubé, 1996 .

Humoral immune response limits gene therapy in canine MPS I.

C. Lutzko, H. Kiem, I. Dubé, 1996, Blood.

Megakaryoblastic Leukemia in a Dog

R. Denovo, M. Mccracken, R. Shull, 1986, Veterinary pathology.

Radiographic findings in a canine model of mucopolysaccharidosis I. Changes associated with bone marrow transplantation.

R. Shull, M. Walker, 1988, Investigative radiology.

Inappropriate marrow release of hematopoietic precursors in three dogs.

R. Shull, 1981, Veterinary pathology.

Dexamethasone-induced serum biochemical changes in goats.

J. Maddux, W. E. Moore, R. Shull, 1988, American journal of veterinary research.

Integration of problem-based learning in a veterinary medical curriculum: first-year experiences with Application-Based Learning Exercises at the University of Tennessee College of Veterinary Medicine.

R. Shull, I. Lane, J. Brace, 2002, Journal of veterinary medical education.

Alterations in neuron morphology in mueopolysaccharidosis type I * A Golgi study

S. Walkley, M. Haskins, R. Shull, 2022 .

Bilateral torsion of uterine horns in a nongravid bitch.

D. Caywood, R. Shull, G. Johnston, 1978, Journal of the American Veterinary Medical Association.

The value of anion gap and osmolal gap determination in veterinary medicine.

R. Shull, 1978, Veterinary clinical pathology.

Membranous glomerulonephropathy and nephrotic syndrome associated with iatrogenic metallic mercury poisoning in a cat.

R. Vernier, C. Osborne, R. Shull, 1981, Veterinary and human toxicology.

Acquired hyposegmentation of granulocytes (pseudo-Pelger-Huët anomaly) in a dog.

R. Shull, D. Powell, 1979, The Cornell veterinarian.

Cardiovascular changes after bone marrow transplantation in dogs with mucopolysaccharidosis I.

G. Constantopoulos, J. Scott, R. Gompf, 1990, American journal of veterinary research.